AbCellera Biologics Inc. ABCL Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from AbCellera Biologics Inc.’s reported figures.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s invested capital?
- AbCellera Biologics Inc. (ABCL) reported invested capital of $976.2M in Q1 2026.
- How has AbCellera Biologics Inc.'s invested capital changed year-over-year?
- AbCellera Biologics Inc.'s invested capital increased by 7.7% year-over-year, from $906.56M to $976.2M.
- What is the long-term trend for AbCellera Biologics Inc.'s invested capital?
- Over 5 years (2020 to 2025), AbCellera Biologics Inc.'s invested capital has grown at a 32.4% compound annual growth rate (CAGR), from $240.97M to $981.61M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).